BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2700
+0.0030 (1.12%)
At close: Feb 18, 2026, 4:00 PM EST
0.2650
-0.0050 (-1.85%)
Pre-market: Feb 19, 2026, 7:23 AM EST
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$34,855
Profits / Employee
-$1,151,862
Market Cap
5.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | 5 | -1 | -16.67% | 5 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 28 |
| Theriva Biologics | 22 |
| Purple Biotech | 9 |
| Alzamend Neuro | 7 |
| Mustang Bio | 6 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
| Xenetic Biosciences | 2 |
BRTX News
- 5 days ago - BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewsWire
- 7 days ago - BioRestorative Announces Pricing of $5.0 Million Public Offering - GlobeNewsWire
- 8 days ago - BioRestorative Announces Positive Outcome from Type B Meeting with FDA - GlobeNewsWire
- 3 months ago - BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - GlobeNewsWire
- 4 months ago - BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - GlobeNewsWire
- 4 months ago - BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio - GlobeNewsWire
- 4 months ago - BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit - GlobeNewsWire